2021 - 2022

Client
Wellcome Trust
Wellcome Trust
Assessment of the Factors Enabling the Rapid Development and Authorisation of COVID-19 Vaccines
MMGH conducted an assessment on behalf of the Wellcome Trust to understand the impact of different factors which enabled the rapid clinical development and regulatory authorisation for COVID-19 vaccines. The project approach is comprised of extensive stakeholder surveys and interviews complemented by a literature review, quantitative analyses, including a regression analysis, and expert focus groups. Together, these activities identified the key factors that influenced the clinical development timelines for COVID-19 vaccines and highlighted which factors could be replicated in future vaccine development efforts.
Related Publication(s)
2022
Covid-19 vaccines: the factors that enabled unprecedented timelines for clinical development and regulatory authorisation...
Author
Melissa Ko
Melissa Ko
Abstract
Historically, clinical development and approval of vaccines have spanned approximately 10 years with only ~16% of vaccine candidates ever receiving market authorisation. The long timelines and the low success rates are the product of the complex ecosystem where each vaccine...